nicotinamide mononucleotide has been researched along with galactose in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dilxat, T; Lin, J; Liu, X; Qiu, T; Shi, Q | 1 |
| Kothari, D; Li, Y; Liang, J; Niu, K; Ru, M; Wang, R; Wang, W; Wu, X; Zhai, Z | 1 |
| Hou, Y; Ji, C; Li, M; Shen, S; Wei, C; Wu, Y; Zhang, S | 1 |
1 trial(s) available for nicotinamide mononucleotide and galactose
| Article | Year |
|---|---|
Bazi Bushen capsule attenuates cognitive deficits by inhibiting microglia activation and cellular senescence.
Topics: Animals; Calcium; Cellular Senescence; Cognition; Cyclin-Dependent Kinase Inhibitor p16; Disks Large Homolog 4 Protein; Galactose; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Microglia; Nicotinamide Mononucleotide; Proliferating Cell Nuclear Antigen; Receptors, Immunologic; RNA, Messenger | 2022 |
2 other study(ies) available for nicotinamide mononucleotide and galactose
| Article | Year |
|---|---|
The combination of nicotinamide mononucleotide and lycopene prevents cognitive impairment and attenuates oxidative damage in D-galactose induced aging models via Keap1-Nrf2 signaling.
Topics: Aging; Animals; Cognitive Dysfunction; Drug Therapy, Combination; Galactose; Gene Expression Regulation; Kelch-Like ECH-Associated Protein 1; Lycopene; Male; Morris Water Maze Test; NF-E2-Related Factor 2; Nicotinamide Mononucleotide; Oxidative Stress; PC12 Cells; Rats; Signal Transduction; Spatial Learning; Treatment Outcome | 2022 |
Nicotinamide mononucleotide supplementation protects the intestinal function in aging mice and D-galactose induced senescent cells.
Topics: Aging; Animals; Antioxidants; Cellular Senescence; Claudin-1; Dietary Supplements; Galactose; Mice; NAD; Nicotinamide Mononucleotide; Occludin; RNA, Messenger; Sirtuins | 2022 |